Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 18, 2024 |
print number 8345a |
Jan 18, 2024 |
amend and recommit to health |
Jan 03, 2024 |
referred to health |
Dec 13, 2023 |
referred to health |
Assembly Bill A8345A
2023-2024 Legislative Session
Sponsored By
RAJKUMAR
Current Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Bill Amendments
2023-A8345 - Details
2023-A8345 - Summary
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
2023-A8345 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 8345 2023-2024 Regular Sessions I N A S S E M B L Y December 13, 2023 ___________ Introduced by M. of A. RAJKUMAR -- read once and referred to the Commit- tee on Health AN ACT to amend the public health law, in relation to enacting the "New York affordable drug manufacturing act" THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Short title. This act shall be known and may be cited as the "New York affordable drug manufacturing act". § 2. Article 2-A of the public health law is amended by adding a new title IV to read as follows: TITLE IV NEW YORK AFFORDABLE DRUG MANUFACTURING ACT SECTION 282. DEFINITIONS. 283. PARTNERSHIPS; PRODUCTION AND DISTRIBUTION OF PRESCRIPTION DRUGS. 284. REPORTING. 285. PROPRIETARY INFORMATION. § 282. DEFINITIONS. AS USED IN THIS TITLE, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS: 1. "GENERIC DRUG" MEANS A DRUG THAT IS APPROVED PURSUANT TO SUBDIVI- SION (J) OF SECTION 355 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT (21 U.S.C. SEC. 301 ET SEQ.), OR A BIOSIMILAR, AS DEFINED UNDER THE FEDERAL PUBLIC HEALTH SERVICE ACT (42 U.S.C. SEC. 262). 2. "PARTNERSHIPS" SHALL INCLUDE, BUT ARE NOT LIMITED TO, AGREEMENTS FOR THE PROCUREMENT OF GENERIC PRESCRIPTION DRUGS BY WAY OF CONTRACTS OR PURCHASING BY A PAYER, STATE GOVERNMENTAL AGENCY, GROUP PURCHASING ORGANIZATION, NONPROFIT ORGANIZATION, OR OTHER ENTITY. § 283. PARTNERSHIPS; PRODUCTION AND DISTRIBUTION OF PRESCRIPTION DRUGS. 1. (A) THE COMMISSIONER SHALL ENTER INTO PARTNERSHIPS, CONSISTENT WITH PARAGRAPH (B) OF SUBDIVISION TWO OF THIS SECTION, IN CONSULTATION WITH ALL APPROPRIATE STATE AGENCIES AND THE DEPARTMENT OF HEALTH OR EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD08090-01-3
2023-A8345A (ACTIVE) - Details
2023-A8345A (ACTIVE) - Summary
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
2023-A8345A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 8345--A 2023-2024 Regular Sessions I N A S S E M B L Y December 13, 2023 ___________ Introduced by M. of A. RAJKUMAR -- read once and referred to the Commit- tee on Health -- recommitted to the Committee on Health in accordance with Assembly Rule 3, sec. 2 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the public health law, in relation to enacting the "New York affordable drug manufacturing act" THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Short title. This act shall be known and may be cited as the "New York affordable drug manufacturing act". § 2. Article 2-A of the public health law is amended by adding a new title IV to read as follows: TITLE IV NEW YORK AFFORDABLE DRUG MANUFACTURING ACT SECTION 282. DEFINITIONS. 283. PARTNERSHIPS; PRODUCTION AND DISTRIBUTION OF GENERIC PRESCRIPTION DRUGS. 284. REPORTING. 285. PROPRIETARY INFORMATION. § 282. DEFINITIONS. AS USED IN THIS TITLE, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS: 1. "GENERIC PRESCRIPTION DRUG" MEANS A DRUG THAT IS APPROVED PURSUANT TO AN APPLICATION SUBMITTED UNDER SUBDIVISION (J) OF SECTION 355 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT (21 U.S.C. SEC. 301 ET SEQ.), OR A BIOSIMILAR, AS DEFINED UNDER THE FEDERAL PUBLIC HEALTH SERVICE ACT (42 U.S.C. SEC. 262) THAT IS NOT UNDER PATENT. 2. "PARTNERSHIPS" MEANS AGREEMENTS FOR THE PROCUREMENT OF GENERIC PRESCRIPTION DRUGS BY WAY OF CONTRACTS OR PURCHASING BY A PAYER, STATE GOVERNMENTAL AGENCY, GROUP PURCHASING ORGANIZATION, NONPROFIT ORGANIZA- TION, OR OTHER ENTITY. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD08090-03-3 A. 8345--A 2
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.